Skip to main content
. Author manuscript; available in PMC: 2009 Oct 5.
Published in final edited form as: Ann Intern Med. 2008 Nov 4;149(9):601–611. doi: 10.7326/0003-4819-149-9-200811040-00003

APPENDIX TABLE 6.

EFFECTS OF TREATMENT ON FUNCTION

BASELINE 6 MONTHS 12 MONTHS
Mean (SD) minimum-maximum Mean Change * 95% CI P Value MK-677 vs. Placebo Mean Change * 95% CI P Value MK-677 vs. Placebo
FUNCTION TESTS
30 m walk, sec Placebo N=21 14.5 (2.8) 9.5-21.2 N=21 -0.1 N=21 0.2
MK-677 N=40 14.3 (2.9) 9.0-20.5 N=40 -0.3 N=40 -0.2
30 m walk, m/sec Placebo N=21 2.14 (0.40) 1.42-3.17 N=21 0.04 N=21 -0.01
MK-677 N=40 2.19 (0.47) 1.46-3.32 N=40 0.05 N=40 0.06
30 m walk/TASM, sec/kg Placebo N=21 0.89 (0.39) 0.36-1.64 N=21 -0.01 -0.04 - 0.03 N=21 0.01 -0.02 - 0.04
MK-677 N=40 0.88 (0.33) 0.32-1.42 N=40 -0.01 -0.04 - 0.01 >.99 N=40 -0.01 -0.03 - 0.01 0.30
6 min walk, m Placebo N=20 422 (58) 267-534 N=19 8 N=20 5
MK-677 N=40 426 (58) 334-567 N=40 9 N=40 11
6 min walk, # laps Placebo N=20 4.7 (0.7) 3.0-6.0 N=19 0.1 N=20 0.1
MK-677 N=40 4.8 (0.7) 3.8-6.4 N=40 0.1 N=40 0.1
6 min walk, # laps/TASM Placebo N=20 0.28 (0.08) 0.15-0.41 N=19 0.004 -0.004-0.013 N=20 0.002 -0.005-0.009
MK-677 N=40 0.28 (0.06) 0.16-0.45 N=40 0.005 -0.001-0.011 >.99 N=40 0.006 0.001-0.011 0.44
Sit-Stand x 5, sec Placebo N=17 11.0 (2.8) 7.4-18.2 N=17 -0.6 N=17 -0.1
MK-677 N=30 11.2 (2.2) 7.3-16.6 N=30 -0.6 N=30 -0.3
Sit-Stand x 5/TASM, sec/kg Placebo N=17 0.70 (0.31) 0.27-1.3 N=17 -0.04 -0.10 - 0.02 N=17 0.00 -0.06 - 0.05
MK-677 N=30 0.68 (0.23) 0.26-1.04 N=30 -0.04 -0.09 - 0.01 >.99 N=30 -0.03 -0.07 - 0.01 0.37
FUNCTION TESTS
Stairs - DOWN, sec Placebo N=19 16.6 (3.7) 12.5-27.5 N=19 0.1 N=19 0.4
MK-677 N=38 17.7 (4.8) 10.7-32.2 N=38 -0.3 N=38 -0.3
Stairs -DOWN/TASM, sec/kg Placebo N=19 1.0 (0.5) 0.4-1.9 N=19 0.01 -0.05 - 0.07 N=19 0.03 -0.03 - 0.08
MK-677 N=38 1.1 (0.5) 0.4-2.0 N=38 -0.02 -0.07 - 0.02 0.91 N=38 -0.03 -0.06 - 0.01 0.180
Stairs - UP, sec Placebo N=20 17.9 (4.1) 12.7-29.6 N=20 0.0 N=20 0.2
MK-677 N=39 19.4 (4.9) 10.8-31.9 N=39 0.1 N=39 0.3
Stairs - UP/TASM, sec/kg Placebo N=20 1.09 (0.49) 0.44-2.06 N=20 -0.01 -0.06 - 0.05 N=20 0.02 -0.03 - 0.07
MK-677 N=39 1.20 (0.51) 0.36-2.09 N=39 0.01 -0.03 - 0.05 >.99 N=39 0.02 -0.02 - 0.05 0.97

Baseline data presented are the arithmetic mean (SD) and the minimum and maximum values; N for each test is indicated.

*

Mean change (arithmetic difference) from baseline with 95% confidence limits at 6 months and at 12 months

P values are for the pivotal comparisons between the two groups at 6 months and at 12 months.

Function variables were analyzed per kg TASM at baseline.

Empty cells = no statistical analyses were performed; raw data are reported in typical units for comparison

TASM = total appendicular skeletal muscle mass from DXA